Skip to content
Clinical Trials – home

Universita' Campus Bio-medico Di Roma

Verified siteinfo

Italy Via Alvaro Del Portillo N 200, 00128 Rome, Italy

  • 101 trials recruiting
  • Non-small cell lung cancer · Sjogren's syndrome · Metabolic dysfunction-associated steatohepatitis
  • Adults and children

About Specializations

Universita' Campus Bio-medico Di Roma in Rome, Italy specialises in clinical trials of conditions such as Non-small cell lung cancer, Sjogren's syndrome, Metabolic dysfunction-associated steatohepatitis, Migraine, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases Research

At Universita' Campus Bio-medico Di Roma in Rome, the clinical trial activity is centered on cardiovascular diseases, with a focused effort on understanding and preventing myocardial injury in people hospitalized with pneumonia. The studies are designed to assess whether a potential add-on therapy can help protect the heart while patients are being treated for infection.

  • Testing a new supportive therapy aimed at reducing myocardial injury in patients with pneumonia
  • Evaluating the safety and effectiveness of a treatment approach in a hospitalized population
  • Exploring the link between severe respiratory illness and heart-related complications

This research area reflects a close intersection between cardiology and infectious disease care, with the goal of improving outcomes for patients at risk of cardiac damage during respiratory illness.

Myocardial Injury Prevention Studies

The site is also conducting trials focused specifically on preventing myocardial injury in the setting of pneumonia. These studies aim to determine whether an additional treatment can offer heart protection for hospitalized patients and support safer recovery during acute illness.

  • Assessing whether a candidate therapy may help prevent heart injury during pneumonia
  • Studying treatment effectiveness in reducing cardiac complications
  • Supporting better management of patients with overlapping cardiovascular and respiratory risks

With 51 investigators involved across 5 clinical trials, the research program shows a strong collaborative effort within the Department of Cardiovascular Diseases to address a clinically important complication of infection.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Site location
Via Alvaro Del Portillo N 20000128 RomeItaly
Recruiting now
101 trials
Conditions studied
167
Partner status
Verified site

More sites in RomeItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

275 clinical trials

Cardiac failure

Recruiting

Study of maridebart cafraglutide for patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Obesity+1

Recruiting

A Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:AZD6234
  • Sponsor:AstraZeneca AB

Phase 3 Randomized, Double‑Blind Study of Telitacicept versus Placebo for Efficacy and Safety in Adults with Active Primary Sjögren’s Disease

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Telitacicept
  • Sponsor:Vor Biopharma Inc.

A Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Efimosfermin alfa
  • Sponsor:Glaxosmithkline Research & Development Limited

Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:ZL-1310
  • Sponsor:Zai Lab (US) LLC

Obesity+2

Recruiting

A study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

Obesity+2

Recruiting

A study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

A Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Survodutide
  • Sponsor:Boehringer Ingelheim International GmbH

A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Survodutide
  • Sponsor:Boehringer Ingelheim International GmbH

Breast cancer

Recruiting

Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BioNTech SE

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.